Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial

Rodney P E Pollard, Wayel H Abdulahad, Arjan Vissink, Nishath Hamza, Johannes G M Burgerhof, Jiska M Meijer, Annie Visser, Minke G Huitema, Fred K L Spijkervet, Cees G M Kallenberg, Hendrika Bootsma, Frans G M Kroese

Research output: Contribution to journalArticleAcademicpeer-review

54 Citations (Scopus)
Original languageEnglish
Pages (from-to)146-8
Number of pages3
JournalAnnals of the Rheumatic Diseases
Volume72
Issue number1
DOIs
Publication statusPublished - Jan-2013

Keywords

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • B-Cell Activating Factor
  • Double-Blind Method
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Sjogren's Syndrome
  • Tumor Necrosis Factor Ligand Superfamily Member 13

Cite this